Here are three insights:
1. While Medtronic confirmed the purchase, the acquisition costs were not disclosed. Market analyst estimate the purchase was around $44.8 million.
2. Cropson develops minimally invasive medical devices to treat and diagnose gastrointestinal disorders.
3. Medtronic plans to use the acquisition to expand its existing GI portfolio to include solutions for oesophageal disease.
More articles on devices and implants:
Most orthopedic device educational material overly complex for patients — 4 insights
Smith & Nephew, Stryker & more: 7 device company mergers, acquisitions & agreements
Intuitive Surgical leads global robotic surgical market with da Vinci line: 4 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.